Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of CRX100 in Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04282044
Recruitment Status : Recruiting
First Posted : February 24, 2020
Last Update Posted : April 2, 2021
Sponsor:
Information provided by (Responsible Party):
BioEclipse Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2022
Estimated Study Completion Date : May 2022